Search INSM
INSMED Inc
Nasdaq · CIK 1104506
Last close111.12
Daily change+2.53 (2.33%)
10 Years gain+663.19%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
INSM · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
61.8Momentum
100.0Acceleration
100.0Confidence
77.0Annual Revenue16
Quarterly Revenue58
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality18.7 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 5.4316 percentage points.
Operating leverageOperating margin improved by 169.5038 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 20.1769%.
Key Metrics
Revenue Growth TTM178.68%OK
Revenue CAGR 3Y35.2%OK
Gross Margin82.46%OK
Operating Margin-84.97%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-796.7%OK
Incremental Operating Margin 3Y-78.04%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y20.18%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $606.42M | $483.49M | -$1.25B | -$935.01M | -$967.58M | 79.73% | -205.59% | -159.55% | n/a | 199.01M |
| 2025 FY Dec 31, 2024 | $363.71M | $277.97M | -$878.25M | -$683.88M | -$705.81M | 76.43% | -241.47% | -194.06% | -3,612.42% | 164.04M |
| 2025 FY Dec 31, 2023 | $305.21M | $239.64M | -$709.63M | -$536.25M | -$549.54M | 78.52% | -232.51% | -180.05% | -705.15% | 140.43M |
| 2024 FY Dec 31, 2022 | $245.36M | $190.23M | -$457.32M | -$400.44M | -$410.32M | 77.53% | -186.39% | -167.23% | -122.99% | 123.04M |
| 2023 FY Dec 31, 2021 | $188.46M | $144.31M | -$375.09M | -$363.30M | -$370.59M | 76.57% | -199.03% | -196.64% | -86.29% | 112.11M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $981.21M | sum latest 4 fiscal quarters Revenue | OK | 0001104506-26-000041, 0001104506-25-000053 |
| Revenue Growth TTM | 178.68% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104506-26-000041, 0001104506-25-000053 |
| Revenue CAGR 3Y | 35.2% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001104506-26-000009 |
| Revenue CAGR 5Y | 29.83% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001104506-26-000009 |
| Gross Profit CAGR 3Y | 36.47% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001104506-26-000009 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001104506-26-000041, 0001104506-25-000053 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 82.46% | Gross Profit / Revenue | OK | 0001104506-26-000041, 0001104506-25-000053 |
| Operating Margin | -84.97% | Operating Income / Revenue | OK | 0001104506-26-000041, 0001104506-25-000053 |
| ROIC | -796.7% | NOPAT / Average Invested Capital | OK | 0001104506-26-000041, 0001104506-25-000053 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104506-26-000041 |
| Current Ratio | 3.72x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 2.12x | (Cash + Short-term Investments) / Total Debt | OK | 0001104506-26-000041 |
| Revenue per Diluted Share | $4.51 | Revenue / Diluted Shares | OK | 0001104506-26-000041, 0001104506-25-000053 |